Varespladib methyl in cardiovascular disease.
Rosenson, Robert S
Varespladib methyl in cardiovascular disease. [electronic resource] - Expert opinion on investigational drugs Oct 2010 - 1245-55 p. digital
Publication Type: Journal Article; Review
1744-7658
10.1517/13543784.2010.517193 doi
Acetates--adverse effects
Animals
Atherosclerosis--complications
Biomarkers
Cardiovascular Diseases--drug therapy
Cholesterol, LDL--blood
Clinical Trials as Topic
Coronary Disease--drug therapy
Disease Models, Animal
Drug Evaluation, Preclinical
Female
Humans
Indoles--adverse effects
Inflammation--physiopathology
Keto Acids
Male
Phospholipases A2, Secretory--antagonists & inhibitors
Varespladib methyl in cardiovascular disease. [electronic resource] - Expert opinion on investigational drugs Oct 2010 - 1245-55 p. digital
Publication Type: Journal Article; Review
1744-7658
10.1517/13543784.2010.517193 doi
Acetates--adverse effects
Animals
Atherosclerosis--complications
Biomarkers
Cardiovascular Diseases--drug therapy
Cholesterol, LDL--blood
Clinical Trials as Topic
Coronary Disease--drug therapy
Disease Models, Animal
Drug Evaluation, Preclinical
Female
Humans
Indoles--adverse effects
Inflammation--physiopathology
Keto Acids
Male
Phospholipases A2, Secretory--antagonists & inhibitors